Stock Events

Stock Events

Penumbra 

$322.17
53
+$1.03+0.32% 19:59 Today
+$0.00+0%20:00After hours

Statistics

Day High
322.72
Day Low
321.77
52W High
362.41
52W Low
221.26
Volume
174,064
Avg. Volume
346,576
Mkt Cap
12.69B
P/E Ratio
73.46
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.67
0.85
1.03
1.2
Expected EPS
1.204073
Actual EPS
N/A

Financials

12.66%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.4BRevenue
177.69MNet Income

Analyst Ratings

335.00Average Price Target
The highest estimate is 350.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PEN. It's not an investment recommendation.
Apple
12
AAPL
Microsoft
12
MSFT
Amazon
12
AMZN
Tesla
10
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific offers a wide range of medical devices that compete with Penumbra's neurovascular and peripheral vascular products.
Medtronic
MDT
Mkt Cap116.77B
Medtronic provides medical devices for various conditions, including those that overlap with Penumbra's market, such as neurovascular devices.
Smith & Nephew
SNN
Mkt Cap12.12B
Smith & Nephew competes in the medical technology market, offering products that can be used in similar procedures as Penumbra's.
Stryker
SYK
Mkt Cap126.84B
Stryker operates in the medical technology field, offering neurotechnology and spine products that compete with Penumbra's offerings.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet competes in the musculoskeletal healthcare market, which can overlap with Penumbra's interventional therapies.
Edwards Lifesciences
EW
Mkt Cap52B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing in the broader cardiovascular market with Penumbra.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical, known for its robotic surgical systems, competes in the high-tech end of medical devices, indirectly competing with Penumbra's innovative solutions.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its medical devices segment, offers a broad range of products that compete across several of Penumbra's markets.
Integra Lifesciences
IART
Mkt Cap1.31B
Integra LifeSciences offers products in neurosurgery, reconstructive and general surgery, directly competing with some of Penumbra's surgical solutions.

About

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
Show more...
CEO
Adam Elsesser
Employees
4700
Country
United States
ISIN
US70975L1070
WKN
000A14Y65

Listings

STU
DE
0P8.STU
XETRA
DE
0P8.XETRA
BOATS
BOATS
PEN.BOATS
MU
DE
0P8.MU

0 Comments

Share your thoughts

FAQ

What is Penumbra stock price today?▼
The current price of PEN is $322.17 USD — it has increased by +0.32% in the past 24 hours. Watch Penumbra stock price performance more closely on the chart.
What is Penumbra stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Penumbra stocks are traded under the ticker PEN.
Is Penumbra stock price growing?▼
PEN stock has risen by +0.15% compared to the previous week, the month change is a -0.63% fall, over the last year Penumbra has showed a +15.18% increase.
What is Penumbra market cap?▼
Today Penumbra has the market capitalization of 12.69B
When is the next Penumbra earnings date?▼
Penumbra is going to release the next earnings report on November 04, 2026.
What were Penumbra earnings last quarter?▼
PEN earnings for the last quarter are 0.88 USD per share, whereas the estimation was 1.16 USD resulting in a -24.3% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Penumbra revenue for the last year?▼
Penumbra revenue for the last year amounts to 1.4B USD.
What is Penumbra net income for the last year?▼
PEN net income for the last year is 177.69M USD.
How many employees does Penumbra have?▼
As of September 04, 2026, the company has 4,700 employees.
In which sector is Penumbra located?▼
Penumbra operates in the Health & Wellness sector.
When did Penumbra complete a stock split?▼
Penumbra has not had any recent stock splits.
Where is Penumbra headquartered?▼
Penumbra is headquartered in ALAMEDA, United States.